BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities-Reference-Cited by-全球学者库

BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities

Published:2010-10-12 Issue:1 Volume:102 Page:182-191
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Hu Chih-Bo,Chen Ching-Ping,Yeh Teng-Kuang,Song Jen-Shin,Chang Chi-Yen,Chuu Jiunn-Jye,Tung Fei-Feng,Ho Pei-Yin,Chen Tung-Wei,Lin Chi-Hung,Wang Min-Hsien,Chang Kai-Yen,Huang Chen-Lung,Lin Heng-Liang,Li Wen-Tai,Hwang Der-Ren,Chern Jyh-Haur,Hwang Ling-Ling,Chang Jang-Yang,Chao Yu-Sheng,Chen Chiung-Tong

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01744.x/fullpdf

Reference42 articles.

1. Vinorelbine (Navelbine): a third-generation Vinca alkaloid;Budman;Cancer Invest,1997

2. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest;Kamath;Cancer Res,2003

3. Docetaxel: an alternative taxane in ovarian cancer;Katsumata;Br J Cancer,2003

4. Resistance to taxol in lung cancer cells associated with increased microtubule dynamics;Goncalves;Proc Natl Acad Sci USA,2001

5. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells;Kavallaris;Cancer Res,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry;Pharmaceuticals;2023-07-12

2. BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways;International Journal of Molecular Sciences;2022-11-15

3. Indole derivatives (2010–2020) as versatile tubulin inhibitors: synthesis and structure–activity relationships;Future Medicinal Chemistry;2021-10

4. Utilisation of Chick Embryo Chorioallantoic Membrane as a Model Platform for Imaging-Navigated Biomedical Research;Cells;2021-02-22

5. An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer;Journal of Medicinal Chemistry;2015-12-01